Clinical Trial Update: EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is testing Vicadrostat together with empagliflozin in people with type 2 diabetes, hypertension, and cardiovascular disease and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Vicadrostat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 3 | Status: RECRUITING